Jon Entine, the executive director of the Genetic Literacy Project, and a Senior Fellow at the World Food Center, Institute
ebola
Forbes Matthew Herper, who has been regularly covering the Ebola story since it broke, recently presented an in-print debate concerning the best way to handle this potentially scary situation.
Ebola has come to New York City and Americans continue to worry about the possibility of an Ebola epidemic in the United States, apparently even going so far as to buy sham Ebola cures online. However, two New York Times articles argue that the possibility of an Ebola epidemic in the US is still highly unlikely.
Bioengineered crops save lives, so why are so many against it? The CDC has good news on vaccination rates in the U.S., but we're not at 100% yet. More Ebola fears, this time, a community takes it a bit too far.
Since there is hardly a day that goes by without a good dose of mind-numbing idiocy about Ebola, we figured ACSH ought to weigh in now and then. After all, the worst Ebola science isn t a whole lot different
The latest in health news: knee injuries from unsuspected source, why the CDC's strategy on Ebola isn't working, and what if you could have the burger without the calories?
As we mentioned earlier this week, ACSH s Dr. Josh Bloom is not a big fan of how the CDC is attempting to control the spread of Ebola.
He has written an op-ed on Science 2.0, entitled Preventing Ebola: Screen Or Screen Door? which reflects this rather clearly.
There is no hotter topic in the news these days than the Ebola outbreak. We would say that it has gone viral, but that would be beneath us.
Opinions and reactions range from the end of the world to absolutely nothing to worry about.
We thought it might be a good time to examine some of the different opinions and advisories, as well facts, unknown facts and suppositions.
All over the news today is the anti-Ebola drug ZMAPP (which hasn t even been proven to work), and the difficulties in making large quantities of it.
ACSH s Dr. Bloom comments, The good news is that since 52 percent of the people in the US think GM foods are unsafe, Mapp Biopharmaceutical, the maker of the drug should really only need to make half as much.
Why is this? Let s take a look at how ZMAPP is made.
With one definite case of Ebola hemorrhagic fever (and one other possible) having been diagnosed in Dallas, those who said it can t happen here have been proven wrong. What about those warning of an epidemic? Also wrong.
In his recent opinion piece published in the New York Post, ACSH friend and former trustee (and former FDA official) Dr. Henry Miller questions the FDA s decision to grant permission for expanded access to